Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


1. Participate in the care of transplant patients with input received from the various disciplines involved.

2.Discuss new publications.

3. Discuss how to improve upon current practice based on information learned from quality improvement projects.

4. Discuss updates to institutional standard operating procedures with regard to stem cell transplantation

Target Audience

The primary target audience for this activity are the physicians involved in patient care, any consulting departments (Infectious Disease, Psychiatry, Pharmacy etc) other staff members involved in stem cell transplant coordination (ie: NP, blood bank, nursing, administration).

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement:

Vaishali Sanchorawala, Speaker and Course Director, has no relevant financial relationships to disclose.

Sakina Flint, Program Manager, has no relevant financial relationships to disclose.

Faculty disclosure of off-label use:

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.